NewswireToday - /newswire/ -
Paris, Ile-de-France, France, 2010/04/12 - Bio-Modeling Systems is selected by Medicen, the Paris region leading life sciences cluster, and the other National clusters to represent collaborative R&D excellence at the Fast Track “R&D Partnering with France” during BiO Chicago May 3.
BMSystems is selected by French life science clusters to present its disruptive science & business model during BiO in Chicago.
• Collaborative Research & Business excellence: Bio-Modeling Systems is selected by Medicen, the Paris region leading life sciences cluster, and the other National clusters to represent collaborative R&D excellence at the Fast Track “R&D Partnering with France” during BiO Chicago, May 3rd, 2010. Bio-Modeling Systems’ presentation (“New collaborative R&D paradigm deciphered and its first operational successes in CNS, biodefense/biosecurity and Green Industrial Biotech”) will focus on the operational benefits generated by its disruptive science & business model. Do not hesitate to meet us at this event.
• New collaborative R&D player in the field of antibody improvement. Pherecydes-Pharma (pherecydes-pharma.com), our fully operational industrial spin-off, will announce during BiO Chicago the signature of a major collaborative R&D agreement with a European partner in antibody improvement based on its proprietary TAPE technology, a patented BMSystems' discovery transferred to Pherecydes-Pharma.
• Business opportunities: BMSystems, member of BiO, will participate to BiO 2010 partnering forum in Chicago. Do not hesitate to meet us during the partnering forum or at the French Booth 3712 for business updates and possible collaborations.
For sustainable business, time to market is a critical issue. Why wait for the failure of your strategic internal R&D plan before starting your external Plan B?
Bio-Modeling Systems, a world leading R&D booster for life sciences discoveries, can help you save considerable time and resources immediately.